Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tafluprost Preserved vs Unpreserved in Glaucoma/OHT
NCT00918346Phase 3Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Sep 2005
- Primary completion
- Mar 2006
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of tafluprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Santen Pharmaceutical. Started Sep 2005; status: completed.
02
Drugs
tafluprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00918346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918346.